|
XPO4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.981680E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.832420E-04 |
| Normal-vs-Stage2 |
3.545400E-01 |
| Normal-vs-Stage3 |
2.918300E-03 |
| Normal-vs-Stage4 |
2.735300E-03 |
| Stage1-vs-Stage2 |
3.699600E-01 |
| Stage1-vs-Stage3 |
7.788000E-01 |
| Stage1-vs-Stage4 |
6.470600E-01 |
| Stage2-vs-Stage3 |
3.177800E-01 |
| Stage2-vs-Stage4 |
3.519200E-01 |
| Stage3-vs-Stage4 |
7.470200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.397500E-04 |
| Normal-vs-AfricanAmerican |
1.104460E-02 |
| Normal-vs-Asian |
9.377200E-04 |
| Caucasian-vs-AfricanAmerican |
8.364200E-01 |
| Caucasian-vs-Asian |
3.693200E-01 |
| AfricanAmerican-vs-Asian |
3.211800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.92299999996126E-06 |
| Normal-vs-Female |
4.505800E-01 |
| Male-vs-Female |
1.251640E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.215460E-03 |
| Normal-vs-Extreme_Weight |
4.07260000000464E-05 |
| Normal-vs-Obese |
6.166000E-02 |
| Normal-vs-Extreme_Obese |
7.244100E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.662400E-01 |
| Normal_Weight-vs-Obese |
2.199400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.919400E-01 |
| Extreme_Weight-vs-Obese |
7.176500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.170800E-01 |
| Obese-vs-Extreme_Obese |
2.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.857540E-03 |
| Normal-vs-Age(41-60Yrs) |
2.068100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.401510E-04 |
| Normal-vs-Age(81-100Yrs) |
1.64557999999815E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.928000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.574600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.995400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.384750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.015720E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.129800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.01460000000187E-05 |
| Normal-VS-Type2 PRCC |
2.076100E-03 |
| Normal-VS-KIRP CIMP |
4.469700E-02 |
| Normal-VS-Unclassified PRCC |
6.518400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.823400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.699200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.093800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.585000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.032440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.084600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55629999999407E-05 |
| Normal-vs-N1 |
3.988100E-02 |
| Normal-vs-N2 |
1.159840E-04 |
| N0-vs-N1 |
2.481800E-01 |
| N0-vs-N2 |
2.318200E-01 |
| N1-vs-N2 |
1.255390E-01 |
|
|
